Ignite Creation Date:
2025-12-24 @ 5:18 PM
Ignite Modification Date:
2026-02-18 @ 12:55 AM
Study NCT ID:
NCT00845650
Status:
COMPLETED
Last Update Posted:
2024-03-18
First Post:
2009-02-13
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Pharmacokinetics Study of Anthrax Immune Globulin Intravenous (AIGIV)
Sponsor:
Emergent BioSolutions
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-02
Start Date Type:
None
Primary Completion Date:
2010-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-10
Completion Date Type:
ACTUAL
First Submit Date:
2009-02-13
First Submit QC Date:
None
Study First Post Date:
2009-02-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-05-11
Results First Submit QC Date:
None
Results First Post Date:
2018-06-13
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2012-11-22
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2024-03-14
Last Update Post Date:
2024-03-18
Last Update Post Date Type:
ACTUAL